Cefapirin
From Wikipedia, the free encyclopedia
 |
|
|
Cefapirin
|
|
| Systematic (IUPAC) name | |
| (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7- {[(pyridin-4-ylsulfanyl)acetyl]amino}-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H17N3O6S2 |
| Mol. mass | 423.466 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
B(US) |
| Legal status | |
| Routes | Intravenous, intramuscular |
Cefapirin (INN, also spelled cephapirin) is a first-generation cephalosporin antibiotic. It is marketed under the trade name Cefadyl.
It also has a role in Veterinary Medicine as Metricure, an intrauterine preparation and combined with prednisolone in Mastiplan, an intramammary preparation. Both licenced in Cattle.
|
||||||||||||||||||||
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
